| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 47.672 | 6.411 | 989 | 3.573 | 0 | 1.737 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 54.825 | 11.003 | 5.265 | 5.870 | 19.421 | 6.353 | 855 | 883 | 1.072 | 253 |
| Total Expenses - EUR | 54.283 | 30.155 | 25.399 | 20.271 | 19.949 | 23.021 | 18.526 | 23.356 | 14.660 | 15.551 |
| Gross Profit/Loss - EUR | 542 | -19.152 | -20.134 | -14.401 | -528 | -16.668 | -17.670 | -22.473 | -13.588 | -15.298 |
| Net Profit/Loss - EUR | 113 | -19.262 | -20.173 | -14.450 | -716 | -16.731 | -17.677 | -22.473 | -13.593 | -15.300 |
| Employees | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Farmaceutic C.t.m.c. Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 170.222 | 162.848 | 154.549 | 146.987 | 139.739 | 132.772 | 125.606 | 121.760 | 117.169 | 112.315 |
| Current Assets | 112.772 | 97.871 | 85.951 | 79.708 | 72.270 | 59.251 | 52.493 | 37.762 | 34.988 | 23.501 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 18.520 | 14.208 | 9.487 | 6.788 | 6.851 | 6.895 | 6.857 | 6.877 | 14.052 | 7.356 |
| Cash | 2.227 | 161 | 666 | 1.960 | 44.601 | 31.388 | 24.797 | 12.434 | 20.936 | 1.139 |
| Shareholders Funds | 281.492 | 259.359 | 234.798 | 216.039 | 211.139 | 190.405 | 168.506 | 146.555 | 132.518 | 116.477 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 1.680 | 1.608 | 5.832 | 10.801 | 1.142 | 1.929 | 9.929 | 13.141 | 19.813 | 19.659 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Farmaceutic C.t.m.c. Srl